Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study
World Journal of Gastroenterology · 28.07.2026
DOI: 10.3748/wjg.123331 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.07.2026. Verfasst von Guo-Jie Feng und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Feng, G., Fu, C., Wang, F., Li, J., Jiang, Y., Wang, X., Yang, B., Xu, W., Zhang, Y., Cheng, X., Ge, X., Xia, X., Xi, H., Zhao, X., Ma, H., Zhao, X., Wang, X., & Li, B. (2026). Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.123331
Vancouver
Feng G, Fu C, Wang F, Li J, Jiang Y, Wang X, et al. Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.123331
BibTeX
@article{Feng2026,
author = {Feng, Guo-Jie and Fu, Cheng-Rui and Wang, Fan and Li, Jian-Cheng and Jiang, Yue and Wang, Xin-Yi and Yang, Bai-Hua and Xu, Wen-Cai and Zhang, Yao-Wen and Cheng, Xin-Yu and Ge, Xiao-Lin and Xia, Xiao-Jie and Xi, He-Ming and Zhao, Xue-Song and Ma, Hong-Bing and Zhao, Xi-Xi and Wang, Xin and Li, Bao-Sheng},
title = {Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study},
journal = {World Journal of Gastroenterology},
year = {2026},
doi = {10.3748/wjg.123331}
}
EUVIMED